英国/爱尔兰围产期HIV感染青少年转成人管理时的临床状况
该研究基于英国/爱尔兰CHIPS前瞻性队列,分析644名围产期HIV感染青少年转成人管理时的临床状态。转诊时中位年龄17.4岁,76%正在接受抗逆转录病毒治疗(ART),其中74%病毒载量<400 c/mL。有耐药数据的291人中,82%对至少一类药物耐药,12%存在三类耐药。
要点
- 转诊时76%的青少年在ART中,其中74%实现病毒载量<400 c/mL。
- 27%有既往艾滋病诊断,CD4中位数444 cells/mm3。
- 有耐药数据者中82%对至少一类药物耐药,12%为三类耐药。
核心结论
- 约四分之三的围产期HIV感染青少年转成人管理时在稳定ART中,其中74%病毒学抑制。
- 三类耐药患病率相对较低,为12%。
研究设计与样本
- 分析英国/爱尔兰国家Collaborative HIV Pediatric Study(CHIPS)前瞻性队列数据。
- 1996年至2014年11月CHIPS随访的1907名儿童中,644名(34%)转入成人管理。
主要发现
- 转诊时中位年龄17.4岁(IQR 16.5–18.1),53%为女性,62%在英国/爱尔兰以外出生,75%为非洲黑人。
- 转诊时27%有既往艾滋病诊断,CD4为444 cells/mm3(IQR 280–643),76%在ART中,13%停ART,11%未治疗。
- ART患者中74%病毒载量<400 c/mL。
- 多变量分析中,转诊时较高CD4与较年轻年龄、ART启动时较高CD4及转诊时较低病毒载量相关(P ≤ .001)。
- 病毒抑制的预测因素包括无艾滋病诊断和较晚转诊年份(P ≤ .05)。
临床怎么用
- 转诊前应评估ART状态、病毒载量和CD4,识别未抑制及耐药患者以优化成人管理衔接。
局限性
- 耐药分析仅基于291名有数据患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasing numbers of children infected perinatally with human immunodeficiency virus (HIV) are surviving to adolescence and transitioning to adult care, yet there are scarce data on their clinical status at transfer. METHODS: We analyzed prospective cohort data from the UK/Ireland national Collaborative HIV Pediatric Study (CHIPS). Clinical status at last pediatric clinic visit prior to transfer was described. Factors associated with higher CD4 cell count and viral load (VL) suppression<400 c/mL among patients on antiretroviral therapy (ART) at transfer were assessed using linear and logistic regression, respectively. Data were matched with the UK HIV Drug Resistance Database (UKHIVDRB) to assess cumulative resistance profiles at transfer. RESULTS: Of 1,907 children followed in CHIPS from 1996 to November 2014, 644 (34%) transferred to adult care: 53% were female, 62% born outside the UK/Ireland, 75% black African. At last pediatric follow-up, median age was 17.4 years [interquartile range 16.5,18.1], 27% had previous AIDS diagnosis, CD4 was 444 cells/mm3 [280, 643], 76% were on ART, 13% off-ART, and 11% ART-naive. Among patients on ART, 74% had VL<400 c/mL. In multivariable analysis, higher CD4 at transfer was associated with younger age, higher CD4 at ART initiation and lower VL at transfer (P ≤ .001). Predictors of viral suppression include no AIDS diagnosis and later year of transfer (P ≤ .05). Of 291 patients with resistance data, 82% had resistance to ≥1 drug class, 56% to ≥2 classes and 12% had triple-class resistance. CONCLUSION: Three-quarters of adolescents were on stable ART at transfer, of whom 74% were virologically suppressed. The prevalence of triple-class resistance was relatively low at 12%.
引用
- Collins IJ, Foster C, Tostevin A, et al. Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clin Infect Dis. 2017. PMID: 28329212. doi:10.1093/cid/cix063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。